Back
Open Access

Physiological determinants underlying a meaningful improvement in VO2peak following exercise training in anthracycline-treated breast cancer survivors

Session: Managing cardiovascular risk in cancer patients
Topic: Cardio-Oncology
Speaker: Doctor S. Foulkes (Edmonton, CA)
Event: ESC Preventive Cardiology 2024

Congress Presentation

Add to my library

Like

About the speaker

Doctor Stephen Foulkes

University of Alberta, Edmonton (Canada)
1 presentation
0 follower

4 more presentations in this session

Cardiac rehabilitation and long-term prognosis in cardiovascular disease patients with cancer history

Speaker: Mr T. Miki (Sagamihara, JP)

Access
Abstract
Slides
Like
Thumbnail

Impact of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in cancer patients: a systematic review and meta-analysis of heart failure hospitalisation and mortality.

Speaker: Doctor J. Meng (Norwich, GB)

Access
Abstract
Slides
Like
Thumbnail

Cardiovascular health profile of cancer survivors: real-world insights from the Polish Norwegian Study (PONS)

Speaker: Doctor G. Vaidean (Miami, US)

Access
Abstract
Slides
Like
Thumbnail

Peak oxygen uptake impairment in childhood cancer survivors treated with anthracycline-based chemotherapy: a systematic-review and meta-analysis

Speaker: Doctor S. Foulkes (Edmonton, CA)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Managing cardiovascular risk in cancer patients

Speakers: Doctor S. Foulkes, Mr T. Miki, Doctor J. Meng, Doctor G. Vaidean, Doctor S. Foulkes
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2024

25 April - 27 April 2024

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources